p53 at the crossroads between cancer and neurodegeneration.
about
The associations between Parkinson's disease and cancer: the plot thickensDiametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunologyPulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanismsA neuroprotective phase precedes striatal degeneration upon nucleolar stress.Mitochondrial matrix P53 sensitizes cells to oxidative stress.Risk of Alzheimer's disease or dementia following a cancer diagnosis.p53 and mitochondrial function in neurons.Contribution of S6K1/MAPK signaling pathways in the response to oxidative stress: activation of RSK and MSK by hydrogen peroxideBRCA1 and p53 tumor suppressor molecules in Alzheimer's disease.Identifying genes that mediate anthracyline toxicity in immune cellsProgrammed cell death in aging.The Machado-Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53DNA-dependent protein kinase and DNA repair: relevance to Alzheimer's disease.Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression.ASPP2 involvement in p53-mediated HIV-1 envelope glycoprotein gp120 neurotoxicity in mice cerebrocortical neurons.Ginkgolic Acid Protects against Aβ-Induced Synaptic Dysfunction in the Hippocampus.DNA Repair Defects and DNA-PK in Neurodegeneration.Conversion of fibroblasts to neural cells by p53 depletion.Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.MicroRNAs in cancers and neurodegenerative disorders.Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders.Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease.Mitochondrial dynamics regulating chemoresistance in gynecological cancers.Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer's Disease.Drug target identification at the crossroad of neuronal apoptosis and survival.Zyxin is a novel target for β-amyloid peptide: characterization of its role in Alzheimer's pathogenesis.Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis.Regulator of Cell Cycle (RGCC) Expression During the Progression of Alzheimer's Disease.Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.Neuroanatomical Distribution of DEK Protein in Corticolimbic Circuits Associated with Learning and Memory in Adult Male and Female Mice.Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer's disease.Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons
P2860
Q26778641-DC1486B5-E148-4C5C-B6A7-D6E945BC5019Q26782139-104156BC-841A-4F2E-8FE2-1DC6F7ABBFD7Q28297490-2317A927-8454-494E-811D-3B832F502A50Q30549660-8CA55A6D-92F7-422F-B12E-BBC0B655B809Q33616298-75D0F37E-6871-4AD9-852C-20267247292FQ33817462-972173AD-1463-4E4C-A4F9-C1E9CF9806FBQ33819250-4A37B6E0-E374-4C4F-AA89-AAD5FDF2D931Q34995113-F55B9698-6B51-4812-99DC-994CB7B578E8Q35138955-33B5DC9D-AC56-418B-A1EC-6E236A9A93C8Q35429116-0AF2E7BF-9DE6-4C8C-9EDA-B08EF7CAAD66Q35779447-9DDEB1D7-9617-43C7-8B65-148F155AE6D7Q36193918-3E79ACC9-61E7-4C76-95AA-932E74E5817DQ36998015-41A8735F-382E-47C4-AF9F-7B09301DECBFQ37073657-4EB97A0F-0773-457E-82BD-670D4C74E4EBQ37254459-CEB685CF-D842-4973-94F4-4A1405872CCDQ37366123-8DA4BE00-239B-4CD0-BF3F-AFC58DCA8D5EQ37558796-EC141453-1210-41A7-844E-4DDE429CA0C5Q37609952-ECB3462A-1583-44C3-AC42-EDD0F8AEACECQ37725397-E07E5908-6DE4-4AE9-80B1-EFD07BF98A69Q38051332-5186E454-E323-431B-A33F-E0714E9144FEQ38091301-EDA7B2FF-9181-4C58-A2C7-3C7ABDD78552Q38316418-101EC2E0-32B2-42FD-AFC2-35C573BC51A9Q38587869-1C86E5A1-1C2E-4591-B56B-82EA86B21136Q38825382-ED013810-6AE6-44F7-A78D-83E20D07867CQ39076381-3FDCD656-FA1F-49CB-A4B4-E6B4D8C9227BQ39208501-4DDF04D2-8B53-4E66-9D9E-D0CCE6B6498BQ41589802-6DCF9979-799D-488D-B590-9AB9AF360966Q43266310-E4BE8F5F-7C34-448F-8297-283A1EB28DC7Q46784328-D4D7C933-0A87-4181-B0A4-286B45A0F7ADQ47365416-EBBE5A4F-8B60-43CA-BE72-9517884718B5Q47658813-1829CE6F-D8D2-47B7-A012-2D5584A25135Q58698855-20D19B2A-6263-46C9-8BA2-AA7A5DC46AC0
P2860
p53 at the crossroads between cancer and neurodegeneration.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
p53 at the crossroads between cancer and neurodegeneration.
@en
p53 at the crossroads between cancer and neurodegeneration.
@nl
type
label
p53 at the crossroads between cancer and neurodegeneration.
@en
p53 at the crossroads between cancer and neurodegeneration.
@nl
prefLabel
p53 at the crossroads between cancer and neurodegeneration.
@en
p53 at the crossroads between cancer and neurodegeneration.
@nl
P2093
P1476
p53 at the crossroads between cancer and neurodegeneration.
@en
P2093
Cristina Lanni
Daniela Uberti
Maurizio Memo
P304
P356
10.1016/J.FREERADBIOMED.2012.02.034
P577
2012-03-03T00:00:00Z